# Xention Discovery

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xention-discovery

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.xention.com
- Total disclosed funding: $33M
- Latest round: Series D (Nov 24, 2010)
- Investors on record: 10

## About

Xention Discovery Ltd. is a technology company specializing in healthcare solutions, focused on software and data integration to enhance patient monitoring and management through innovative digital platforms.Founded in 2002, Xention Discovery Ltd. is based in Cambridge, UK, and specializes in healthcare technology solutions. The company has successfully completed five deals, with its most recent funding round occurring in March 2011 when it raised GBP 12 million in Grant financing, bringing the total amount raised to GBP 12.7 million. Details about the founder and CEO are currently unavailable.Xention specializes in providing solutions tailored to the healthcare sector, focusing on software and technology integration that enhances patient monitoring and management. Their flagship product is a digital platform that utilizes advanced algorithms and data analytics for real-time health tracking and predictive modeling. This platform addresses challenges in patient engagement and data interoperability, enabling healthcare providers to deliver timely and effective care. The company serves a client base that includes hospitals, clinics, and healthcare professionals primarily in North America and Europe, targeting end users such as patients and caregivers. Since its initial launch, Xention has refined its offerings based on user feedback and industry advancements, strengthening its role in the digital health landscape.In the most recent year of 2016, Xention reported a revenue of GBP 3,436,970.60. The company operates a subscription-based revenue model, where healthcare providers pay for access to its digital health platform and associated services. Clients typically enter into annual contracts that provide various service tiers to accommodate different needs. Xention also engages in strategic partnerships with healthcare organizations, contributing to its revenue through collaborative projects and tailored solutions.Following their most recent funding round in March 2011, Xention Discovery Ltd. is focused on developing new products aimed at enhancing their digital health platform. The company plans to expand into new markets in Asia and Africa by 2025, leveraging the GBP 12 million raised through Grant financing to support these initiatives. This funding is anticipated to be instrumental in enhancing product features and facilitating market entry.

## Funding rounds

- Series D, Nov 24, 2010, $13M — MVM Partners, Seroba, BTG, Forbion, Crédit Agricole Corporate and Investment Bank
- Series B, Jul 12, 2005, $21M — MVM Partners, Quester Capital Management, Omnes Capital, Livingbridge, Capital A, Albany Venture Managers, BTG

## Investors

- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series B, Series D
- Quester Capital Management (https://capitalatlas.ai/funds/quester-capital-management) — Series B
- Omnes Capital (https://capitalatlas.ai/funds/omnes-capital) — Series B
- Livingbridge (https://capitalatlas.ai/funds/livingbridge) — Series B
- Capital A — Series B
- Albany Venture Managers (https://capitalatlas.ai/funds/albany-venture-managers) — Series B
- BTG — Series B, Series D
- Seroba (https://capitalatlas.ai/funds/seroba) — Series D
- Forbion (https://capitalatlas.ai/funds/forbion) — Series D
- Crédit Agricole Corporate and Investment Bank — Series D